Helicobacter Pylori Infections Industry : Reviews of Drug Profiles, Products & Key Players
Upcoming SlideShare
Loading in...5
×
 

Helicobacter Pylori Infections Industry : Reviews of Drug Profiles, Products & Key Players

on

  • 86 views

Complete report is spread across 79 pages and available @ http://www.reportsnreports.com/reports/280058-helicobacter-pylori-infections-pipeline-review-h1-2014.html. ...

Complete report is spread across 79 pages and available @ http://www.reportsnreports.com/reports/280058-helicobacter-pylori-infections-pipeline-review-h1-2014.html.

Helicobacter Pylori Infections - Pipeline Review, H1 2014 report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities.

Statistics

Views

Total Views
86
Views on SlideShare
86
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Helicobacter Pylori Infections Industry : Reviews of Drug Profiles, Products & Key Players Helicobacter Pylori Infections Industry : Reviews of Drug Profiles, Products & Key Players Document Transcript

  • Helicobacter Pylori Infections - Pipeline Review, H1 2014 Helicobacter Pylori Infections - Pipeline Review, H1 2014 Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Helicobacter Pylori Infections Market in subject line and your contact details. Helicobacter Pylori Infections - Pipeline Review, H1 2014, provides an overview of the Helicobacter Pylori Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Helicobacter Pylori Infections Market, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Helicobacter Pylori Infections and special features on late-stage and discontinued projects. The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Complete report is spread across 79 pages and available @ http://www.reportsnreports.com/reports/280058-helicobacter-pylori-infections- pipeline-review-h1-2014.html. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope - The report provides a snapshot of the global therapeutic landscape of Helicobacter Pylori Infections - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Helicobacter Pylori Infections and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects
  • Helicobacter Pylori Infections - Pipeline Review, H1 2014 - A review of the Helicobacter Pylori Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre- registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Helicobacter Pylori Infections pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=280058. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Helicobacter Pylori Infections - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Helicobacter Pylori Infections pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=280058. List of Tables Number of Products under Development for Helicobacter Pylori Infections, H1 2014 9 Number of Products under Development for Helicobacter Pylori Infections - Comparative Analysis, H1 2014 10 Number of Products under Development by Companies, H1 2014 12 Number of Products under Investigation by Universities/Institutes, H1 2014 13 Comparative Analysis by Late Stage Development, H1 2014 14 Comparative Analysis by Clinical Stage Development, H1 2014 15 Comparative Analysis by Early Stage Development, H1 2014 16 Comparative Analysis by Unknown Stage Development, H1 2014 17 Products under Development by Companies, H1 2014 18
  • Helicobacter Pylori Infections - Pipeline Review, H1 2014 Products under Investigation by Universities/Institutes, H1 2014 19 Helicobacter Pylori Infections - Pipeline by Sequella, Inc., H1 2014 20 Helicobacter Pylori Infections - Pipeline by Takeda Pharmaceutical Company Limited, H1 2014 21 Helicobacter Pylori Infections - Pipeline by Affinium Pharmaceuticals, Ltd., H1 2014 22 Helicobacter Pylori Infections - Pipeline by Microbio Co., Ltd., H1 2014 23 Helicobacter Pylori Infections - Pipeline by MerLion Pharmaceuticals Pte Ltd, H1 2014 24 Helicobacter Pylori Infections - Pipeline by ImmunoBiology Ltd., H1 2014 25 Helicobacter Pylori Infections - Pipeline by EpiVax, Inc., H1 2014 26 Helicobacter Pylori Infections - Pipeline by aRigen Pharmaceuticals, Inc., H1 2014 27 Helicobacter Pylori Infections - Pipeline by Vecta Ltd., H1 2014 28 Helicobacter Pylori Infections - Pipeline by Sigmoid Pharma Ltd., H1 2014 29 Helicobacter Pylori Infections - Pipeline by RedHill Biopharma Ltd., H1 2014 30 Assessment by Monotherapy Products, H1 2014 31 Assessment by Combination Products, H1 2014 32 Number of Products by Stage and Target, H1 2014 35 Number of Products by Stage and Mechanism of Action, H1 2014 38 Number of Products by Stage and Route of Administration, H1 2014 40 Number of Products by Stage and Molecule Type, H1 2014 42 Helicobacter Pylori Infections Therapeutics - Recent Pipeline Updates, H1 2014 65 Helicobacter Pylori Infections - Dormant Projects, H1 2014 69 Inquiry Before Buying @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=28005 8. List of Figures Number of Products under Development for Helicobacter Pylori Infections, H1 2014 9 Number of Products under Development for Helicobacter Pylori Infections - Comparative Analysis, H1 2014 10 Number of Products under Development by Companies, H1 2014 11 Comparative Analysis by Clinical Stage Development, H1 2014 15 Comparative Analysis by Early Stage Products, H1 2014 16 Assessment by Monotherapy Products, H1 2014 31 Assessment by Combination Products, H1 2014 32 Number of Products by Top 10 Target, H1 2014 33 Number of Products by Stage and Top 10 Target, H1 2014 34 Number of Products by Top 10 Mechanism of Action, H1 2014 36 Number of Products by Stage and Top 10 Mechanism of Action, H1 2014 37 Number of Products by Top 10 Route of Administration, H1 2014 39 Number of Products by Stage and Top 10 Route of Administration, H1 2014 40 Number of Products by Top 10 Molecule Type, H1 2014 41 Number of Products by Stage and Top 10 Molecule Type, H1 2014 42 Explore Report on Pharmaceuticals & Therapeutic Market.
  • Helicobacter Pylori Infections - Pipeline Review, H1 2014 Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Helicobacter Pylori Infections - Pipeline Review, H1 2014” report OR for any other market research and intelligence needs you may have for your business.